Pyrimidine derivatives for the prevention of HIV infection

This invention concerns the use of a compound for the manufacture of a medicament for the prevention of HIV infection via sexual intercourse and related intimate contact between partners, wherein the compound is a compound of formula a N-oxide, a pharmaceutically acceptable addition salt, a quaterna...

Full description

Saved in:
Bibliographic Details
Main Authors DAEYAERT, FREDERIK, FRANS, DESIRE, LEWI, PAULUS, JOANNES, HEERES, JAN, PASQUIER, ELISABETH, THERESE, JEANNE, DE JONGE, MARC, RENÉ, JANSSEN, PAUL, ADRIAAN, JAN, VINKERS, HENDRIK, MAARTEN, KOYMANS, LUCIEN, MARIA, HENRICUS, GUILLEMONT, JÉRÔME, EMILE, GEORGES
Format Patent
LanguageEnglish
French
German
Published 27.07.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This invention concerns the use of a compound for the manufacture of a medicament for the prevention of HIV infection via sexual intercourse and related intimate contact between partners, wherein the compound is a compound of formula a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine and a stereochemically isomeric form thereof, wherein the ring containing -a1=a2-a3=a4- and -b1=b2-b3=b4- represents phenyl, pyridyl, pyrimidinyl, pirazinyl, pyridazinyl; n is 0 to 5; m is 1 to 4; R1 is hydrogen; aryl; formyl; C1-6alkylcarbonyl; C1-6alkyl; C1-6alkyloxycarbonyl; substituted C1-6alkyl, C1-6alkylcarbonyl, C1-6alkyloxycarbonyl, C1-6alkylcarbonyloxy; substituted C1-6alkyloxyC1-6alkylcarbonyl; R2 is hydroxy, halo, optionally substituted C1-6alkyl, C3-7cycloalkyl, optionally substituted C2-6alkenyl, optionally substituted C2-6alkynyl, C1-6alkyloxy, C1-6alkyloxycarbonyl, carboxyl, cyano, nitro, amino, mono- or di(C1-6alkyl)amino, polyhalomethyl, polyhalomethyloxy, polyhalomethylthio, -S( O)pR6, -NH-S( O)pR6, -C( O)R6, -NHC( O)H, -C( O)NHNH2, -NHC( O)R6, -C( NH)R6 or a 5-membered heterocycle; X1 is -NR5-, -NH-NH-, -N N-, -O-, -C( O)-, C1-4alkanediyl, -CHOH-, -S-, -S( O)p-, -X2-C1-4alkanediyl- or -C1-4alkanediyl-X2-; R3 is NHR13; NR13R14; -C( O)-NHR13; -C( O)-NR13R14; -C( O)-R15; -CH N-NH-C( O)-R16; substituted C1-6alkyl; optionally substituted C1-6alkyloxyC1-6alkyl; substituted C2-6alkenyl; substituted C2-6alkynyl; C1-6alkyl substituted with hydroxy and a second substituent; -C( N-O-R8)-C1-4alkyl; R7; or -X3-R7; R4 is halo, hydroxy, C1-6alkyl, C3-7cycloalkyl, C1-6alkyloxy, cyano, nitro, polyhaloC1-6alkyl, polyhaloC1-6alkyloxy, aminocarbonyl, C1-6alkyloxycarbonyl, C1-6alkylcarbonyl, formyl, amino, mono- or di(C1-4alkyl)amino; and pharmaceutical compositions comprising them.
Bibliography:Application Number: EP20040707937